Breast Cancer Home > Femara
Femara is approved for certain types of breast cancer in postmenopausal women. For example, the drug can be used to treat early breast cancer that is hormone receptor-positive post-surgery and advanced breast cancer that is either hormone receptor-positive or for which the hormone receptor is unknown. Femara comes in tablet form, and is typically taken once a day. Side effects include hot flashes, night sweats, and weight gain.
What Is Femara?Femara® (letrozole) is a prescription medication used to treat breast cancer in postmenopausal women. Specifically, the drug has been licensed to treat postmenopausal women who:
- Have early breast cancer that is hormone receptor-positive and who have had surgery
- Have taken tamoxifen (Nolvadex®, Soltamox™) for five years after surgery or radiation therapy for breast cancer
- Have advanced or metastatic (spreading) breast cancer that is either hormone receptor-positive or hormone receptor-unknown.